Literature DB >> 26181277

JAMA Oncology Patient Page. Neoadjuvant Therapy.

Howard Jack West, Jill Jin.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26181277     DOI： 10.1001/jamaoncol.2015.1241

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

Review 1.  Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC.

Authors:  John F Roller; Nirmal K Veeramachaneni; Jun Zhang
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

2.  Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis.

Authors:  Matthew G Davey; Ferdia Browne; Nicola Miller; Aoife J Lowery; Michael J Kerin
Journal:  BJS Open       Date:  2022-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.